These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 29061503)

  • 1. Outcomes in Severe Hyponatremia Treated With and Without Desmopressin.
    MacMillan TE; Cavalcanti RB
    Am J Med; 2018 Mar; 131(3):317.e1-317.e10. PubMed ID: 29061503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
    Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
    Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin to Prevent Rapid Sodium Correction in Severe Hyponatremia: A Systematic Review.
    MacMillan TE; Tang T; Cavalcanti RB
    Am J Med; 2015 Dec; 128(12):1362.e15-24. PubMed ID: 26031887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia.
    Perianayagam A; Sterns RH; Silver SM; Grieff M; Mayo R; Hix J; Kouides R
    Clin J Am Soc Nephrol; 2008 Mar; 3(2):331-6. PubMed ID: 18235152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of desmopressin acetate in severe hyponatremia in the intensive care unit.
    Rafat C; Schortgen F; Gaudry S; Bertrand F; Miguel-Montanes R; Labbé V; Ricard JD; Hajage D; Dreyfuss D
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):229-37. PubMed ID: 24262506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
    Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
    Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
    Sood L; Sterns RH; Hix JK; Silver SM; Chen L
    Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Relowering of Serum Sodium Concentration Overcomes Disturbances in Consciousness during Hyponatremia Overcorrection and Prevents Osmotic Demyelination Syndrome.
    Ochiai H; Uenishi E
    Intern Med; 2018; 57(16):2353-2357. PubMed ID: 30111674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial.
    Pakchotanon K; Kanjanasuphak N; Chuasuwan A; Gojaseni P; Chittinandana A
    Sci Rep; 2024 Mar; 14(1):7487. PubMed ID: 38553491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Desmopressin in the Management of Severe, Hypovolemic Hyponatremia: A Single-Center, Comparative Analysis.
    Ward FL; Tobe SW; Naimark DMJ
    Can J Kidney Health Dis; 2018; 5():2054358118761051. PubMed ID: 29593879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: A retrospective, propensity score-based, single-center cohort study.
    Jingushi N; Tsuzuki S; Fujii K; Uenishi N; Iwata M; Terasawa T
    J Crit Care; 2021 Aug; 64():53-61. PubMed ID: 33794467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hyponatremia due to desmopressin.
    Kelleher HB; Henderson SO
    J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hyponatremia.
    Sterns RH; Hix JK; Silver S
    Curr Opin Nephrol Hypertens; 2010 Sep; 19(5):493-8. PubMed ID: 20539224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Safety and Efficacy of Desmopressin in Patients With Intracranial Hemorrhage and a History of Alcohol Use.
    Gunther M; Witenko CJ; Prust M; Salerno D; Berger K
    J Intensive Care Med; 2022 Jun; 37(6):825-832. PubMed ID: 34286612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraoperative Use of Desmopressin for Treatment of Profound Hyponatremia in the Setting of Emergency Surgery: A Case Report.
    Watterworth BS; Noorani RJ
    A A Pract; 2018 Jul; 11(2):54-56. PubMed ID: 29634545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral ddAVP for nighttime urinary incontinence in characterized nursing home residents: a pilot study.
    Johnson TM; Miller M; Tang T; Pillion DJ; Ouslander JG
    J Am Med Dir Assoc; 2006 Jan; 7(1):6-11. PubMed ID: 16413428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of hyponatremia with desmopressin use for nocturnal polyuria.
    Choi EY; Park JS; Kim YT; Park SY; Kim GH
    Am J Nephrol; 2015; 41(3):183-90. PubMed ID: 25871541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.
    George JC; Zafar W; Bucaloiu ID; Chang AR
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):984-992. PubMed ID: 29871886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries.
    Sharma R; Stein D
    J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.